Daniel M. Harrison, MD
Associate Professor of Neurology, Director, Multiple Sclerosis Center
UM Faculty Physicians, Inc.
Dr. Harrison is a neurologist. He specializes in the diagnosis and treatment of multiple sclerosis and other inflammatory and autoimmune conditions of the brain, spinal cord and optic nerves.
Dr. Harrison strongly believes in shared decision-making in patient care. Rather than dictating to patients what they must do, he counsels them on the best available data to guide their decisions, walking them through the pros and cons of the available options.
"I prefer patients to make a treatment decision that they are comfortable with, but one that is informed by the best scientific evidence available," he says.
Dr. Harrison is director of the University of Maryland Center for Multiple Sclerosis Treatment and Research. He is also an associate professor of Neurology at University of Maryland School of Medicine.
Dr. Harrison has previously been recognized by Baltimore magazine as a "Top Doctor" honoree in the Neurology-Multiple Sclerosis specialty.
Board Certification and EducationToggle accordion item
Albert Einstein College of Medicine of Yeshiva University, 2004
Long Island Jewish Medical Center, 2005
Columbia-Presbyterian Medical Center, 2008
Johns Hopkins Hospital - Neuroimmunology, 2010
American Board of Psychiatry and Neurology - Neurology, 2008
Hospital AffiliationsToggle accordion item
UM Charles Regional Medical Center
University of Maryland Medical Center
Research and PublicationsToggle accordion item
Dr. Harrison directs an active research program focused on the development and validation of new techniques for imaging of the brain and spinal cord for application to multiple sclerosis research and clinical trials. His research program is currently focused on utilization of novel MRI techniques, including ultra-high-field, 7-tesla MRI for visualization of cortical pathology, neurodegeneration and meningeal inflammation in multiple sclerosis.
Dr. Harrison's research has been funded by the National Institutes of Health, the National Multiple Sclerosis Society, the Department of Defense, and industry partners. He is also an active investigator for the Maryland Center for Multiple Sclerosis clinical trials program.